These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 6339649

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Randomized, double-blind evaluation of azlocillin for the treatment of pulmonary exacerbations of cystic fibrosis.
    McLaughlin FJ, Matthews WJ, Strieder DJ, Sullivan B, Goldmann DA.
    J Antimicrob Chemother; 1983 May; 11 Suppl B():195-203. PubMed ID: 6352602
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Controlled trial of ceftazidime vs. ticarcillin and tobramycin in the treatment of acute respiratory exacerbations in patients with cystic fibrosis.
    Gold R, Overmeyer A, Knie B, Fleming PC, Levison H.
    Pediatr Infect Dis; 1985 May; 4(2):172-7. PubMed ID: 3885181
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Tobramycin and ticarcillin therapy for exacerbations of pulmonary disease in patients with cystic fibrosis.
    Parry MF, Neu HC.
    J Infect Dis; 1976 Aug; 134 Suppl():S194-7. PubMed ID: 823276
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparative evaluation of netilmicin-ticarcillin and tobramycin-ticarcillin in the treatment of serious systemic infections in elderly patients.
    Jansen W, Schwarz A.
    Clin Ther; 1984 Aug; 7(1):112-20. PubMed ID: 6394127
    [Abstract] [Full Text] [Related]

  • 12. Chemotherapy against Pseudomonas aeruginosa in cystic fibrosis. A study of carbenicillin, azlocillin or piperacillin in combination with tobramycin.
    Møller NE, Eriksen KR, Feddersen C, Flensborg EW, Høiby N, Norn S, Rosendal K, Schiøtz PO, Skov PS.
    Eur J Respir Dis; 1982 Mar; 63(2):130-9. PubMed ID: 6461561
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of cefoperazone sodium vs methicillin, ticarcillin, and tobramycin in treatment of pulmonary exacerbations in patients with cystic fibrosis.
    Jewett CV, Ledbetter J, Lyrene RK, Brasfield DM, Tiller RE.
    J Pediatr; 1985 Apr; 106(4):669-72. PubMed ID: 3845095
    [No Abstract] [Full Text] [Related]

  • 15. Efficacy of inhaled tobramycin in the treatment of pulmonary exacerbations in children with cystic fibrosis.
    Stephens D, Garey N, Isles A, Levison H, Gold R.
    Pediatr Infect Dis; 1983 Apr; 2(3):209-11. PubMed ID: 6408619
    [Abstract] [Full Text] [Related]

  • 16. Facilitated detection of antibiotic-resistant Pseudomonas in cystic fibrosis sputum using homogenized specimens and antibiotic-containing media.
    Maduri-Traczewski M, L'Heureux C, Escalona L, Macone A, Goldmann D.
    Diagn Microbiol Infect Dis; 1986 Nov; 5(4):299-305. PubMed ID: 3096628
    [Abstract] [Full Text] [Related]

  • 17. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group.
    Ramsey BW, Pepe MS, Quan JM, Otto KL, Montgomery AB, Williams-Warren J, Vasiljev-K M, Borowitz D, Bowman CM, Marshall BC, Marshall S, Smith AL.
    N Engl J Med; 1999 Jan 07; 340(1):23-30. PubMed ID: 9878641
    [Abstract] [Full Text] [Related]

  • 18. Reduction of sputum Pseudomonas aeruginosa density by antibiotics improves lung function in cystic fibrosis more than do bronchodilators and chest physiotherapy alone.
    Regelmann WE, Elliott GR, Warwick WJ, Clawson CC.
    Am Rev Respir Dis; 1990 Apr 07; 141(4 Pt 1):914-21. PubMed ID: 2109558
    [Abstract] [Full Text] [Related]

  • 19. [Synergistic activity between ticarcillin, azlocillin, cefsulodin, ceftazidime and tobramycin or amikacin against Pseudomonas aeruginosa (author's transl)].
    Petit JC, Richard G, Burghoffer B, Daguet GL.
    Pathol Biol (Paris); 1982 Jun 07; 30(6):426-31. PubMed ID: 6810286
    [Abstract] [Full Text] [Related]

  • 20. Acute pulmonary exacerbations in cystic fibrosis. A double-blind trial of tobramycin and placebo therapy.
    Wientzen R, Prestidge CB, Kramer RI, McCracken GH, Nelson JD.
    Am J Dis Child; 1980 Dec 07; 134(12):1134-8. PubMed ID: 7004176
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.